Labcorp (LH) EVP Amy Summy converts RSUs, withholds shares to cover taxes

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Amy B. Summy reported equity compensation activity involving Restricted Stock Units and common stock. On February 11, 2026, 230 Restricted Stock Units were exercised into 230 shares of Labcorp common stock at an exercise price of $0, increasing her directly held common shares to 5,804.5.

On the same date, 83 shares of common stock were automatically withheld at a price of $289.89 per share to cover tax withholding obligations, leaving her with 5,721.5 directly owned shares. The RSUs were part of a grant vesting in three equal annual installments beginning on February 11, 2026, and she held 1,304 Restricted Stock Units after these transactions.

Insider Trade Summary

230 shares exercised/converted

Mixed 3 txns

Insider Summy Amy B.

Role EVP, Chief Marketing Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	230	$0.00	--
Exercise	Common Stock	230	$0.00	--
Tax Withholding	Common Stock	83	$289.89	$24K

Holdings After Transaction: Restricted Stock Unit — 1,304 shares (Direct); Common Stock — 5,804.5 shares (Direct)

Footnotes (1)

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Stock withholding to satisfy tax withholding obligations. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Summy Amy B.

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		230	A	(1)	5,804.5	D
Common Stock	02/11/2026		F(2)		83	D	$289.89	5,721.5	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			230	(3)	(3)	Common Stock	230	$0	1,304(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Amy B. Summy	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Labcorp (LH) executive Amy B. Summy report?

Amy B. Summy reported exercising 230 Restricted Stock Units into 230 Labcorp common shares at $0 and an automatic withholding of 83 shares at $289.89 to cover taxes. After these transactions, she directly owned 5,721.5 common shares and 1,304 Restricted Stock Units.

How many Labcorp (LH) shares does Amy B. Summy own after the February 11, 2026 transactions?

After the February 11, 2026 transactions, Amy B. Summy directly owned 5,721.5 shares of Labcorp common stock. This figure reflects the net position following the RSU conversion of 230 shares and the tax withholding disposition of 83 shares at $289.89 per share.

What do the Restricted Stock Units reported by Amy B. Summy for Labcorp (LH) represent?

Each Restricted Stock Unit reported by Amy B. Summy represents the contingent right to receive one share of Labcorp common stock. The RSUs are part of an equity grant vesting in three equal annual installments beginning on February 11, 2026, providing equity-based compensation tied to continued service.

Why were 83 Labcorp (LH) shares withheld in Amy B. Summy’s Form 4 filing?

The 83 Labcorp shares were withheld to satisfy tax withholding obligations related to the RSU vesting and conversion. This transaction, coded “F,” is a tax-withholding disposition, meaning shares are surrendered back to the issuer rather than sold in the open market.

How many Labcorp (LH) Restricted Stock Units does Amy B. Summy hold after the reported Form 4 transactions?

Following the February 11, 2026 transactions, Amy B. Summy held 1,304 Restricted Stock Units. This number reflects the aggregate RSUs remaining after 230 units vested and were converted into common stock as part of the scheduled three-year vesting arrangement beginning February 11, 2026.

What is the vesting schedule of Amy B. Summy’s Labcorp (LH) Restricted Stock Units?

The Restricted Stock Units that vested for Amy B. Summy are from a grant that vests in three equal annual installments. Vesting begins on February 11, 2026, with subsequent equal tranches vesting on the same calendar date in the following two years, subject to continued eligibility.